106 related articles for article (PubMed ID: 20543865)
1. Identification of a molecular recognition feature in the E1A oncoprotein that binds the SUMO conjugase UBC9 and likely interferes with polySUMOylation.
Yousef AF; Fonseca GJ; Pelka P; Ablack JN; Walsh C; Dick FA; Bazett-Jones DP; Shaw GS; Mymryk JS
Oncogene; 2010 Aug; 29(33):4693-704. PubMed ID: 20543865
[TBL] [Abstract][Full Text] [Related]
2. Interaction of the E1A oncoprotein with Yak1p, a novel regulator of yeast pseudohyphal differentiation, and related mammalian kinases.
Zhang Z; Smith MM; Mymryk JS
Mol Biol Cell; 2001 Mar; 12(3):699-710. PubMed ID: 11251081
[TBL] [Abstract][Full Text] [Related]
3. Role of an N-terminal site of Ubc9 in SUMO-1, -2, and -3 binding and conjugation.
Tatham MH; Kim S; Yu B; Jaffray E; Song J; Zheng J; Rodriguez MS; Hay RT; Chen Y
Biochemistry; 2003 Aug; 42(33):9959-69. PubMed ID: 12924945
[TBL] [Abstract][Full Text] [Related]
4. Viral oncoproteins E1A and E7 and cellular LxCxE proteins repress SUMO modification of the retinoblastoma tumor suppressor.
Ledl A; Schmidt D; Müller S
Oncogene; 2005 May; 24(23):3810-8. PubMed ID: 15806172
[TBL] [Abstract][Full Text] [Related]
5. Analysis of DNA binding by the adenovirus type 5 E1A oncoprotein.
Avvakumov N; Sahbegovic M; Zhang Z; Shuen M; Mymryk JS
J Gen Virol; 2002 Mar; 83(Pt 3):517-524. PubMed ID: 11842246
[TBL] [Abstract][Full Text] [Related]
6. A functional interaction between RHA and Ubc9, an E2-like enzyme specific for Sumo-1.
Argasinska J; Zhou K; Donnelly RJ; Hay RT; Lee CG
J Mol Biol; 2004 Jul; 341(1):15-25. PubMed ID: 15312759
[TBL] [Abstract][Full Text] [Related]
7. mUBC9, a novel adenovirus E1A-interacting protein that complements a yeast cell cycle defect.
Hateboer G; Hijmans EM; Nooij JB; Schlenker S; Jentsch S; Bernards R
J Biol Chem; 1996 Oct; 271(42):25906-11. PubMed ID: 8824223
[TBL] [Abstract][Full Text] [Related]
8. Adenovirus E1A requires the yeast SAGA histone acetyltransferase complex and associates with SAGA components Gcn5 and Tra1.
Kulesza CA; Van Buskirk HA; Cole MD; Reese JC; Smith MM; Engel DA
Oncogene; 2002 Feb; 21(9):1411-22. PubMed ID: 11857084
[TBL] [Abstract][Full Text] [Related]
9. Identification of a second independent binding site for the pCAF acetyltransferase in adenovirus E1A.
Pelka P; Ablack JN; Shuen M; Yousef AF; Rasti M; Grand RJ; Turnell AS; Mymryk JS
Virology; 2009 Aug; 391(1):90-8. PubMed ID: 19541337
[TBL] [Abstract][Full Text] [Related]
10. Smt3/SUMO and Ubc9 are required for efficient APC/C-mediated proteolysis in budding yeast.
Dieckhoff P; Bolte M; Sancak Y; Braus GH; Irniger S
Mol Microbiol; 2004 Mar; 51(5):1375-87. PubMed ID: 14982631
[TBL] [Abstract][Full Text] [Related]
11. Unique binding interactions among Ubc9, SUMO and RanBP2 reveal a mechanism for SUMO paralog selection.
Tatham MH; Kim S; Jaffray E; Song J; Chen Y; Hay RT
Nat Struct Mol Biol; 2005 Jan; 12(1):67-74. PubMed ID: 15608651
[TBL] [Abstract][Full Text] [Related]
12. Distinct functional domains of Ubc9 dictate cell survival and resistance to genotoxic stress.
van Waardenburg RC; Duda DM; Lancaster CS; Schulman BA; Bjornsti MA
Mol Cell Biol; 2006 Jul; 26(13):4958-69. PubMed ID: 16782883
[TBL] [Abstract][Full Text] [Related]
13. Purification and activity assays for Ubc9, the ubiquitin-conjugating enzyme for the small ubiquitin-like modifier SUMO.
Yunus AA; Lima CD
Methods Enzymol; 2005; 398():74-87. PubMed ID: 16275321
[TBL] [Abstract][Full Text] [Related]
14. Dual role for SUMO E2 conjugase Ubc9 in modulating the transforming and growth-promoting properties of the HMGA1b architectural transcription factor.
Li Y; Lu J; Prochownik EV
J Biol Chem; 2007 May; 282(18):13363-71. PubMed ID: 17350957
[TBL] [Abstract][Full Text] [Related]
15. Interplay between sequence, structure and linear motifs in the adenovirus E1A hub protein.
Glavina J; Román EA; Espada R; de Prat-Gay G; Chemes LB; Sánchez IE
Virology; 2018 Dec; 525():117-131. PubMed ID: 30265888
[TBL] [Abstract][Full Text] [Related]
16. The Cellular Protein Complex Associated with a Transforming Region of E1A Contains c-MYC.
Vijayalingam S; Subramanian T; Zhao LJ; Chinnadurai G
J Virol; 2016 Jan; 90(2):1070-9. PubMed ID: 26559831
[TBL] [Abstract][Full Text] [Related]
17. SUMO Ubc9 enzyme as a viral target.
Varadaraj A; Mattoscio D; Chiocca S
IUBMB Life; 2014 Jan; 66(1):27-33. PubMed ID: 24395713
[TBL] [Abstract][Full Text] [Related]
18. Noncovalent interaction between Ubc9 and SUMO promotes SUMO chain formation.
Knipscheer P; van Dijk WJ; Olsen JV; Mann M; Sixma TK
EMBO J; 2007 Jun; 26(11):2797-807. PubMed ID: 17491593
[TBL] [Abstract][Full Text] [Related]
19. Interaction of moloney murine leukemia virus capsid with Ubc9 and PIASy mediates SUMO-1 addition required early in infection.
Yueh A; Leung J; Bhattacharyya S; Perrone LA; de los Santos K; Pu SY; Goff SP
J Virol; 2006 Jan; 80(1):342-52. PubMed ID: 16352559
[TBL] [Abstract][Full Text] [Related]
20. Differences in the interactions of oncogenic adenovirus 12 early region 1A and nononcogenic adenovirus 2 early region 1A with the cellular coactivators p300 and CBP.
Lipinski KS; Fax P; Wilker B; Hennemann H; Brockmann D; Esche H
Virology; 1999 Mar; 255(1):94-105. PubMed ID: 10049825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
